MARATTO

article · Cureus

Secretory Carcinoma of the Breast: A Rare Entity With Favorable Prognosis

2024Open accessMohamed I University

Abstract

Secretory breast carcinoma (SBC) is an extremely rare entity of breast cancer, which can affect all age groups. The diagnosis is based on the characteristic microscopic appearance, and despite the triple negativity or low hormone receptor positivity, SBC is generally characterized by a favorable prognosis. Due to the rarity of the disease, no clear consensus on optimal treatment is available. Nevertheless, conservative surgery or mastectomy is the main therapeutic option. The efficacy of chemotherapy, radiotherapy, and hormone therapy in this pathology has not been rigorously explored. We report the case of a 65-year-old woman with SBC treated with surgery and adjuvant radiotherapy, with a review of the literature.

Research topics

  • Breast Lesions and Carcinomas
  • Breast Cancer Treatment Studies
  • Cancer and Skin Lesions

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.7759/cureus.60430

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.